Clinical Trial Update: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating haloperidol and lorazepam for delirium in patients with advanced cancer; results posted 2020-10-30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• Lorazepam (Lorazepam)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-10-30